skip to main content
Show Results with:

5 results  for Everything in this catalogue

Refined by: subject: Vaccines--Periodicals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines

Petrecz, Maria et al.

Human vaccines & immunotherapeutics. Volume 15:Issue 2 (2019); pp 426-432 -- Landes Bioscience -- Taylor & Francis

Online access

2
Material Type:
Article
Add to My workspace

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines

Petrecz, Maria et al.

Human vaccines & immunotherapeutics. Volume 15:Number 2 (2019, February 1st); pp 426-432 -- Taylor & Francis

Online access

3
Material Type:
Article
Add to My workspace

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Stacey, Helen L. et al.

Human vaccines & immunotherapeutics. Volume 15:Number 3 (2019, March 4th); pp 530-539 -- Taylor & Francis

Online access

4
Material Type:
Article
Add to My workspace

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Stacey, Helen L. et al.

Human vaccines & immunotherapeutics. Volume 15:Issue 3 (2019); pp 530-539 -- Landes Bioscience -- Taylor & Francis

Online access

5
Material Type:
Article
Add to My workspace

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age

Li, Xiaoming et al.

Vaccine. Volume 33:Issue 12 (2015, March); pp 1499-1505 -- Elsevier Science

Online access

5 results  for Everything in this catalogue

Searching Remote Databases, Please Wait